DRD2 and drug-induced dyskinesia: To determine whether pharmacological activation of A2ARs could mitigate D2R antagonist-induced dyskinesia, we intraperitoneally injected a haloperidol-induced VCM mouse model with CGS 21680A, an A2AR agonist.